Advanced EGFR+ NSCLC

Advanced EGFR+ NSCLC

1

&

2

  • Localized is where the cancer is only in the lung where it first started.
  • This term typically refers to stage 1 or 2 NSCLC. This patient decision aid does not cover stages 1 and 2 NSCLC.
This patient decision aid covers treatment options for stages 3 & 4.

3

  • Locally advanced is where the cancer has spread within the lung to affect lymph nodes near the windpipe. But it has not affected other parts of the body.
  • This is typically called stage 3 NSCLC.

4

  • Metastatic is where the cancer has spread beyond the first lung. This may include the opposite lung, the lining of the lung, or other parts of the body (such as the brain, liver, and bone).
  • This is typically called stage 4 NSCLC.

This site is published by Johnson & Johnson and its affiliates which is solely responsible for its contents. The material on this site is intended only as informational or as an educational aid and it is not intended to be taken as medical advice. The ultimate responsibility for patient care resides with a healthcare professional.

This information is intended for the use of patients and care partners in the United States only. Laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside the United States. Third party trademarks used herein are trademarks of their respective owners. Last updated April 2025.

04/25 cp-445323v2

PrivacyLegal NoticeDo Not Sell or Share My Personal InformationCookie PolicyCookies settings